Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Quest Diagnostics Inc (NYSE:DGX)

Delayed Data
As of Jul 22
 +0.98 / +1.17%
Today’s Change
Today|||52-Week Range
Health Services
Services to the Health Industry

Company Description

Quest Diagnostics, Inc. is engaged in providing diagnostic testing, information and services that help patients, physicians and others to make better healthcare decisions. The company operates through two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services segment comprised of two parts develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, ACOs, IDNs, employers and others. It is a leading provider of diagnostic information services, which includes providing clinical testing services such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing, as well as related services and insights. The segment offer the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, c company-owned patient service centers and phlebotomists in physician offices. The Diagnostic Solutions includes other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology. It offers a variety of solutions for insurers, healthcare providers and others. The segment is the leading provider of risk assessment services for the life insurance industry and testing for clinical trials. It also offers healthcare organizations and clinicians robust information technology solutions and diagnostic products. Quest Diagnostics was founded on December 31, 1996 and is headquartered in Madison, NJ.

Contact Information

Quest Diagnostics, Inc.
3 Giralda Farms
Madison New Jersey 07940
P:(800) 222-0446
Investor Relations:
(973) 520-2900



Mutual fund holders49.89%
Other institutional46.18%
Individual stakeholders27.14%

Top Executives

Stephen H. RusckowskiPresident, Chief Executive Officer & Director
James E. DavisSenior Vice President-Operations
Mark J. GuinanChief Financial Officer & Senior Vice President
Jon Roger CohenChief Medical Officer & Senior Vice President
Lidia L. FonsecaChief Information Officer & Senior Vice President